Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target Site Pharmacokinetics of Voriconazole
NCT01539330Phase 4Completed
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Feb 2009
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in fungal infection, sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Pharmacokinetics of voriconazole in plasma and interstitial space fluid. Started Feb 2009; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT01539330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01539330.